A LONGITUDINAL EXAMINATION OF PROGRESSION-RELATED EVENTS AMONG MEDICARE BENEFICIARIES WITH AND WITHOUT PARKINSON'S DISEASE
Author(s)
Albarmawi H1, Onukwugha E1, Gandhi AB1, Johnson A1, Myers DE2, Gray DL3, Alvir J4, Shulman LM5, Gruber-Baldini A5, Stuart B1
1University of Maryland School of Pharmacy, Baltimore, MD, USA, 2Pfizer, Inc., Collegeville, PA, USA, 3Pfizer Inc, Cambridge, MA, USA, 4Pfizer Inc, New York, NY, USA, 5University of Maryland School of Medicine, Baltimore, MD, USA
OBJECTIVES: Prior Parkinson’s disease (PD) studies are limited by short follow-up and have not reported on events associated with PD progression. The purpose of this study was to characterize PD progression-related events over time among PD cases and compare to PD controls. METHODS: This retrospective cohort study utilized administrative medical and pharmacy claims data from 2005 to 2015 for Medicare beneficiaries represented in the Medicare Chronic Condition Data Warehouse (CCW) 5% sample. We matched cases to controls based on age, race, gender and comorbidities. Cases and controls were required to have at least 7 years of follow-up. We captured the presence of mental health disorders, autonomic dysfunction, falls or fractures (FoF), and fatigue in each year of follow-up. We compared these progression-related events between cases and controls using Pearson’s chi-square tests. RESULTS: The matched sample consisted of 3,570 individuals with 7 years of follow-up. The occurrence of events among cases in years 1, 3, 5 and 7 was as follows. Autonomic dysfunction: 69%, 68%, 73%, 75%; mental health disorders: 53%, 52%, 59%, 66%; FoF: 21%, 18% 20%, 22%; fatigue: 41%, 35%, 36%, 38%, respectively. The occurrence of all four events was higher among cases compared to controls in each year. The largest difference between cases and controls was observed in year 1: autonomic dysfunction (69% vs. 45%, p<0.01); mental health disorders (53% vs. 18%, p<0.01); FoF (21% vs. 9%, p<0.01); fatigue (41% vs. 23%, p<0.01). The differences between cases and controls dropped in year 3, but increased in years 5 and 7. CONCLUSIONS: Progression-related events occurred at significantly higher rates among PD cases compared to controls in each year of follow-up. The differences between cases and controls were highest in year 1. Among cases, the largest increase in autonomic dysfunction and mental health disorders occurred between years 3 and 5.
Conference/Value in Health Info
2019-05, ISPOR 2019, New Orleans, LA, USA
Value in Health, Volume 22, Issue S1 (2019 May)
Code
PND7
Topic
Clinical Outcomes
Topic Subcategory
Clinical Outcomes Assessment
Disease
Neurological Disorders